Patient Portal Technologies, Inc. carries a market capitalization of 1,580.00, placing it among publicly traded companies globally. Its enterprise value stands at 56.05M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1,580.00 |
| Enterprise Value | 56.05M |
Patient Portal Technologies, Inc. currently has 5.00M shares outstanding.
| Shares Outstanding | 5.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 3.94, and the price-to-book ratio stands at -5.55.
| PE Ratio | N/A |
| PS Ratio | 3.94 |
| PB Ratio | -5.55 |
| P/TBV Ratio | 24.37 |
| P/FCF Ratio | 105.02 |
| P/OCF Ratio | -107.39 |
On an enterprise value basis, Patient Portal Technologies, Inc. trades at an EV/EBITDA multiple of 31.57 and an EV/FCF ratio of 66.50.
| EV / Sales | 4.24 |
| EV / EBITDA | 31.57 |
| EV / EBIT | N/A |
| EV / FCF | 66.50 |
Patient Portal Technologies, Inc. maintains a current ratio of 0.68, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 47.97, indicating elevated leverage, while an interest coverage ratio of 5.13 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.68 |
| Quick Ratio | 0.35 |
| Debt / Equity | 47.97 |
| Debt / EBITDA | 2.29 |
| Interest Coverage | 5.13 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -2.56 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | 4,708.00 |
| Effective Tax Rate | N/A |
Patient Portal Technologies, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Patient Portal Technologies, Inc. generated 13.23M in revenue and converted that into -391,918.00 in net income, yielding earnings per share of -0.65. EBITDA reached 1.78M, while operating income came in at -40,893.00.
| Revenue | 13.23M |
| Gross Profit | 6.44M |
| Operating Income | -40,893.00 |
| Pretax Income | -3.01M |
| Net Income | -391,918.00 |
| EBITDA | 1.78M |
| EBIT | -40,893.00 |
| Earnings Per Share (EPS) | -0.65 |
Patient Portal Technologies, Inc. holds 113,164.00 in cash and equivalents against 4.07M in total debt, resulting in a net debt position of 3.32M. Total book value stands at -9.39M, with working capital of -740,409.00 providing operational flexibility.
| Cash & Cash Equivalents | 113,164.00 |
| Total Debt | 4.07M |
| Net Debt | 3.32M |
| Equity (Book Value) | -9.39M |
| Book Value Per Share | -2.04 |
| Working Capital | -740,409.00 |
Patient Portal Technologies, Inc. produced -485,102.00 in operating cash flow over the past twelve months. After subtracting -981,138.00 in capital expenditures, free cash flow totaled -1.47M - equivalent to -0.32 per share.
| Operating Cash Flow | -485,102.00 |
| Capital Expenditures | -981,138.00 |
| Free Cash Flow | -1.47M |
| FCF Per Share | -0.32 |
Patient Portal Technologies, Inc. operates with a gross margin of 48.65, reflecting its pricing power and cost economics. The operating margin of -0.31 and net profit margin of -2.96 provide insight into operational efficiency.
| Gross Margin | 48.65 |
| Operating Margin | -0.31 |
| Pretax Margin | -22.75 |
| Profit Margin | -2.96 |
| EBITDA Margin | 13.42 |
The company's payout ratio of 9.62 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 9.62 |
| Shareholder Yield | -1.70 |
| FCF Yield | 0.95 |
Patient Portal Technologies, Inc.'s most recent stock split took place on November 16, 2010 with a 10:1 split ratio.
| Last Split Date | 11/16/2010 |
| Split Ratio | 10:1 |
Patient Portal Technologies, Inc. posts an Altman Z-Score of 5.40, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.40 |